{
  "ticker": "BG",
  "cik": "0001996862",
  "company_name": "Bunge Global SA",
  "filing_date": "2025-02-20",
  "item1_summary": " The information required by this item with respect to our long-term incentive plan information is found in Part II of this Annual Report on Form 10-K under the caption \"Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities-Securities Authorized for Issuance Under Equity Compensation Plans\"\n Investors should not rely on these representations and warranties as statements of fact . The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Form 10-K . The company will provide information responsive to this Item 14 in our definitive proxy statement for our 2025 Annual Meeting under the caption \"Appointment of Independent Auditor for U.S. Securities Law Reporting\"\n \"Index to Exhibits\" set forth below . Bunge Global SA's other public filings, which are available without charge through the SEC's website at www.sec.gov.u.g.com . The instruments defining the rights of holders of the long-term debt securities of Bunge and its subsidiaries are omitted pursuant to Item 601(b)(4)(iii) of Regulation S-K .\n Bunge Funding Inc., Bunge Management Services Inc., as Servicer, and The Bank of New York, as Trustee (incorporated by reference from Bunge Limited's Form 10-K filed February 19, 2021) The Company's Twenty-Fifth Amendment to Receivables Transfer Agreement, dated May 21, 2024, among Bunge Securitization B.V., as Seller, Koninklijke Bunge B.v. and Bunge Global SA, as Performance Undertaking Provider, Crédit Agricole Corporate & Investment Bank, as Sustainability Co-ordinator .\n Bunge Securitization B.V. as Seller, Bunge Global SA, as Performance Undertaking Provider, Coöperatieve Rabobank U.A. as Administrative Agent, Committed Purchaser and Purchaser Agent . Bunge North America Capital, Inc., Inc., as U.S. Intermediate Transferor, Co. Raboban, as Italian Intermediate transferor, Koninklijke Bunge B.v., as Master Servicer, as Subordinated Lender, and the persons from time to time party thereto as Conduit Purchasers and Purchasers party thereto .\n Second Amendment to the Servicing Agreement, dated June 30, 2016, among Bunge Securitization B.V., as Seller, Bunge North America Capital, Inc., as U.S. Intermediate Transferor, Coöperatieve Rabobank U.A., as Administrative Agent (incorporated by reference from Bunge Limited’s Form 10-K filed on February 28, 2017)\n Bunge Limited’s Form 10-Q filed on August 9, 2011, among Koninklijke Bunge B.V. nd Coöperatieve Rabobank U.A. (f/k/a Bunge Finance B.A.) as Administrative Agent (incorporated by reference from Bunge Ltd.'s Form 10-K filed on February 19, 2021) Table of Contents: Exhibit, Exhibit and Exhibits .\n Bunge Limited, as Guarantor, to Coöperatieve Rabobank U.A., New York Branch, in its capacity as Letter of Credit Agent, and the Bank of New York Mellon, as Collateral Agent . Koninklijke Bunge B.V., as Seller Agent, Bunge North America Capital, Inc., as the Buyer, and Bunge Securitization B.V. as the Transferee .\n Bunge Limited Finance Corp., as Borrower, CoBank, ACB, as Administrative Agent and Lead Arranger, and the several lenders from time to time parties thereto (incorporated by reference from the Registrant’s Form 8-K filed on July 19, 2021) The Credit Agreement incorporated as Exhibit 10.20 hereto was filed July 11, 2023 .\n Bunge Limited, as Guarantor, to Crédit Agricole Corporate and Investment Bank, as Agent, and certain lenders party thereto (incorporated by reference from Bunge’s Form 8-K filed on June 26, 2023) BNP Paribas, Citibank, N.A., Natixis and SMBC Bank International Plc as Arrangers .\n Bunge Limited Finance Corp. as Borrower, JPMorgan Chase Bank, N.A., BNP Paribas, Citibank, ING Bank N.V., JPMorgan Chase . as . Administrative Agent, and the several lenders from time to time parties thereto (incorporated by reference from Bunge. Limited’s Form 8-K filed on June 26, 2023)\n BNP Paribas, as Sustainability Co-ordinators, and Crédit Agricole Corporate and Investment Bank, as Agent, and certain lenders party thereto (incorporated by reference from the Registrant’s Form 8-K filed March 6, 2024) The First Amended and Restated Facility Agreement incorporated as Exhibit 10.32 hereto .\n The Bunge 2024 Long-Term Incentive Plan (incorporated by reference from the Registrant’s Form 8-K filed on May 16, 2024) The plan is based on the Bunge 2016 Equity Incenture Plan . The plan will be amended and restated as of January 1, 2023 (frozen plan as of December 31, 2022)\n Bunge Annual Incentive Plan effective January 1, 2023, and amendment thereto through November 1, . 2023 . Executive Severance Plan (incorporated by reference from Bunge Limited’s Form 10-Q filed on July 27, 2022)       Bunge Executive Severances Plan incorporated by reference from . the Registrant's Form 10,K filed February 22, 2024 . Executive Employment Agreement, dated as of December 20, . and John W. Neppl, is . Bunge Global SA's Chief Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act .\n The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRS document . The instance documents are not in the interactive data file because they are embedded in the document . Exhibit 101 contains a management contract or compensatory plan or arrangement . Portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission .\n The report of Independent Registered Public Accounting Firm (PCAOB ID No. ) The report was published by Bunge Global SA at the time of December 31, 2024 . The report is based on the Consolidated Financial Statements of Income for the Years Ended December 31, 2024, 2023 and 2022 .\n Bunge Global SA and subsidiaries (the \"Company\") as of December 31, 2024 and 2023, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity and redeemable noncontrolling interests . The financial statements present fairly, in all material respects, the financial position of the Company . We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB)\n We conducted our audits in accordance with the standards of the PCAOB. We believe that our audits provide a reasonable basis for our opinion. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion .\n The Company records agricultural commodity inventories, referred to as readily marketable inventories (RMI), and physically settled forward purchase and sale contracts at fair value . A portion of the value is derived using significant unobservable inputs, such as management estimates regarding costs of transportation and other location-related adjustments in Brazil, that involve significant judgment by management .\n The Company has served as the Company's auditor since 2002 . Deloitte & Touche LLP has reviewed the financial results of Bunge Global SA and Subsidiaries . The Company's financial statements are presented at the bottom of the page . The financial statements include: financial statements, statements of interest, foreign exchange (losses) and other income (expense) statements .\n The accompanying notes are an integral part of these consolidated financial statements . Earnings per share—diluted (Note 23) Net income attributable to Bunge shareholders - diluted  $.87-$10.87$ $.51 $.83 $ $1,678 $ $2,337  Net income attributable to Bunge attributable shareholders - diluted .\n The company has $15,958 in cash and short-term debt . The company's net assets include: Property, plant, equipment, plant and equipment, net (Note 7) and $823 carried at fair value) The company paid-in capital: Purchased shares, par value $0.01.01; authorized not issued— $86,861,666 shares; conditionally authorized  - $32,285,894 shares; issued and outstanding: 2024 -  ipient133,964,235; 2023 -   referred noncontrolling interest; $16,109,804 shares .\n The accompanying notes are an integral part of these consolidated financial statements . The following is a summary of the company's financial statements and the corresponding operating expenses . The financial statements are presented in the form of a consolidated financial statements of GUNGE and submarments of cash provided by the company .\n Proceeds from beneficial interest in securitized trade receivables are from proceeds from disposing of business and property, plant and equipment . Cash used for financing activities is from short-term debt with maturities of three months or less less than three months . Cash and cash is used in financing activities .\n The accompanying notes are an integral part of these consolidated financial statements . At the end of the period, cash held for sale - end of period - is $2.72 per share . The following financial statements are presented in the form of a consolidated financial statement . The financial statements include:  qualified shares, non-controlling interests, restricted cash, and cash for sale .\n Shareholders' net loss is $2.6125 per share . Dividends to noncontrolling interests on subsidiary common stock are $1,320 per share. Shareholders’ net income is $9,956 per share and $2,243 per share in compensation expense . Shareholders are entitled to receive a total of $18,835,812 per share from the company .\n The Bunge Global SA completed the change of juriandi on November 1,23, 2018 . Bunge's financial statements are an integral part of these consolidated financial statements . The company's net income was $1.1 billion . The net balance was $16,726,697,697. The net value was $2.40 per share . The cost of the company's operating expenses was $6,692,000 .\n Bunge Global SA is a leading global agribusiness and food company . References to the term \"shares\" refer to Bunge Limited common shares prior to the Redomestication of incorporation of its group holding company from Bermuda to Switzerland . The registered shares began trading on the New York Stock Exchange (the \"NYSE\") under the symbol \"BG\" on November 1, 2023 .\n Bunge's Agribusiness segment is an integrated, global business involved in the purchase, storage, transport, processing, and sale of agricultural commodities . The Refined and Specialty Oils segment produces and sells edible oil products, such as packaged and bulk oils and fats, shortenings, margarines, mayonnaise, and other products derived from the vegetable oil refining process .\n Bunge completed the sale of our  roughly 50% ownership share in BP Bunge Bioenergia to BP on October 1, 2024 . Argentina has experienced hyperinflation, high fiscal deficit and negative Gross Domestic Product (\"GDP\") growth in recent years . Argentina’s government has introduced preferential exchange rates under the Export Programs .\n Bunge’s Ukrainian operations comprise two oilseed crushing facilities, located in Mykolaiv and Dnipropetrovsk . The scope, intensity, duration, and outcome of the ongoing war is uncertain, and any continuation or escalation of the war may have a material adverse effect on Bunge, including its Ukrainian operations . No impairments or charges related to the war were recorded during the year ended December 31, 2024 .\n The accounting policies used to prepare these financial statements are the same as those used for the consolidated financial statements in prior years . Equity investments in which Bunge has the ability to exercise significant influence but does not have a controlling financial interest are accounted for by the equity method of accounting . Noncontrolling interests in subsidiaries related to subsidiary related to Bunge's ownership interests of less than 100% are reported .\n The Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use . Prior period activity has been reclassified to conform to current presentation . The noncontrolling ownership interests in Bunge's earnings, net of tax, is reported as Net (income) attributable to Noncontrolling interests .\n The Company generally records all such assets and liabilities on a gross basis, even when they are subject to master netting agreements . Bunge's reporting currency is the U.S. dollar . Amounts included in the consolidated statements of income, comprehensive income, cash flows, and changes in equity are translated using average exchange rates .\n In accordance with U.S. GAAP, if a foreign entity's economy is determined to be highly inflationary, its financial statements are remeasured as if the functional currency were the reporting currency . Foreign currency translation adjustments are recorded in the consolidated balance sheets as a component of Accumulated other comprehensive loss . The resulting exchange gain or loss is included in Bunge's consolidated statements of income as Foreign exchange gains (losses) - net .\n Bunge establishes allowances for uncollectible trade accounts receivable based on lifetime expected credit losses using an aging schedule for each pool . Pools are determined based on risk characteristics such as the type of customer and geography . The default rate is derived using a provision matrix with data based on historical receivables information . Uncollectible accounts are  purposefully written off when a settlement is reached for an amount that is less than the outstanding historical balance .\n Uncollectible accounts are written off when a settlement is reached for an amount below the outstanding historical balance or when Bunge has determined that collection is unlikely . Secured advances to suppliers bear interest at contractual rates that reflect current market interest rates at the time of the transaction . There are no imputed interest amounts to be amortized under the interest method .\n Readily marketable inventories are agricultural commodity inventories that are readily convertible to cash . Bunge determines fair value based on the price that would be received for an asset or paid to transfer a liability . Inventories other than RMI are stated at the lower of cost or net realizable value by inventory product class .\n The fair value standard describes three levels within its hierarchy that may be used to measure fair value: fair value level 1, level 2 and level 3 . Unobservable inputs are inputs that are based on market data obtained from sources independent of Bunge that reflect the assumptions market participants would use in pricing the asset or liability .\n Bunge does not view nonperformance risk to be a significant input to fair value for the majority of its forward commodity purchase and sale contracts . The majority of Bunge's exchange-traded agricultural commodity futures are settled daily, and therefore such futures are not included in the assets and liabilities that are accounted for at fair value on a recurring basis .\n Bunge's use of these instruments is generally intended to mitigate exposure to market variables . The changes in fair values of derivative instruments designated as fair value hedges, along with the gains or losses on the related hedged items are recorded in earnings in the consolidated statements of income . Bunge may designate certain derivative instruments as net investment hedges to hedge the exposure associated with its equity investments in foreign operations .\n Bunge classifies its marketable debt securities and short-term investments as available-for-sale, held-to-maturity, or held-on-trading . Unrealized gains (losses) are included in Accumulated other comprehensive loss in the consolidated balance sheets . All changes in the fair value of a forward derivative contract are recorded as a component of Accumulation of the accumulated other compound losses .\n Bunge capitalizes eligible costs to acquire or develop internal-use software that are incurred during the application development stage . Maintenance and repairs are expensed as incurred . Goodwill represents the cost in excess of the fair value of net assets acquired in a business acquisition . Bunge's annual impairment testing is generally performed during the fourth quarter of its fiscal year .\n Bunge reviews its property, plant and equipment and finite-lived intangible assets for impairment whenever events or changes in circumstances indicate that carrying amounts may not be recoverable . Bunge bases its evaluation of recoverability on such indicators as the nature, future economic benefits and geographic locations of the assets, historical or future profitability measures, and other external market conditions .\n Bunge reviews its investments annually or when an event or circumstances indicate that a potential decline in value may be other than temporary . Bunge considers various factors in determining whether to recognize an impairment charge, including the length of time the fair value of the investment is expected to be below its carrying value, the financial condition, operating performance and near-term prospects of the affiliate .\n Certain of the Company’s sales in its Refined and Specialty Oils and Milling segments also qualify as derivatives, primarily sales of commodities like bulk soybean and canola oil . Bunge generally does not apply the normal purchase and normal sale exception available under ASC 815 to these contracts . From inception through settlement, these forward sales arrangements are recorded at fair value . unrealized gains and losses recognized in Cost of goods sold and carried on the consolidated balance sheets as current assets or current liabilities .\n The Company recognizes revenue from these contracts at a point in time when it satisfies a performance obligation by transferring control of a product to a customer . The transaction price is generally allocated to performance obligations on a relative standalone selling price basis . Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue producing transaction are excluded from revenue .\n The Company recognizes revenue in the Agribusiness segment from ocean freight and port services over time, as the related services are performed . The Company’s contracts generally provide customers the right to reject any products that do not meet agreed quality specifications . Share-based compensation expense is recognized on a straight-line basis over the requisite service period . The provision for income taxes includes income taxes currently payable and deferred income taxes resulting from temporary differences between the carrying amo\n The Company qualifies for business incentives from governmental entities at various localities in which the Company operates . The programs primarily consist of tax incentives and cash grants designed to promote regional social and economic development or to incentivize production of clean energy . Government grants are accounted for by analogy to International Accounting Standard 20,  Accounting for Government Grants and Disclosure of Government Assistance .\n Bunge receives cash grants from a governmental agency from the sale of clean energy . The program is valid through 2032 and contains recapture features if the Company does not follow program production efficiency requirements . At December 31, 2024, and 2023, Bunge recognized a $2.2 billion reduction to Other current liabilities related to benefits not yet realized .\n The standard is intended to enhance transparency of income statement disclosures, primarily through additional disaggregation of relevant expense captions . ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after Dec. 15 . Bunge is currently evaluating the impact of the standard on its consolidated financial statements .\n The FASB issued ASU 2023-09,  Improvements to Income Tax Disclosures (Topic 740) The new requirements apply to all entities subject to income taxes and will be effective for annual periods beginning after December 15, 2024 . The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted .\n The Sellers are expected to own approximately 30.30% of the combined Bunge company on a fully diluted basis, before giving effect to any share repurchases by Bunge occurring after June 13, 2023 . Bunge intends to use a portion of the proceeds from the Acquisition Financing and Senior Notes issuance to fund the cash consideration for Bunge's Acquisition of Viterra .\n The Acquisition is expected to receive the remaining regulatory approvals and close in the next few months . The Business Combination Agreement may be terminated by mutual written consent of the parties and includes certain customary termination rights . Bunge Finance Europe B.V. (\"BFE\") is a wholly owned finance subsidiary of Bunge, as issuer, and Bunge as guarantor .\n Bunge Global SA's Board of Directors approved the expansion of an existing share repurchase program resulting in an aggregate purchase authorization of $2.0 billion . During the period June 13, 2023 through December 31, 2024, Bunge repurchased 17,558,624,000,000 shares for $1.7 billion . Espaçogrãos agreed to acquire three grain elevators and related assets for total cash consideration of approximately $395,000 .\n On April 14, 2023, Bunge completed its purchase of Fuji Oils New Orleans, LLC's port-based refinery . Bunge expects to finance the transaction through cash from operations and existing financing facilities . The acquisition is expected to close in early 2025, subject to customary closing conditions . The refinery is located in International-Matex Tank Terminals' Avondale Terminal, in Avondal, Louisiana .\n Bunge entered into a definitive stock purchase agreement with Repsol Industrial Transformation, SLU, a wholly owned subsidiary of Repsol SA . Bunge will divest 40% of its Spanish operating subsidiary, Bunge Iberica SA (\"BISA\"), in exchange for approximately $300 million plus up to $40 million in contingent payments, subject to certain purchase price adjustments . The transaction close resulted in a pretax gain on sale of $395 million .\n On September 16, 2022, Bunge signed an agreement to sell its remaining Russian operations, primarily comprising an oilseed crushing and refining facility in Voronezh, southwest Russia . The purchase price adjustment and cumulative translation adjustment losses, among other items related to the disposal group, resulted in a corresponding impairment loss on sale of $103,000 . On February 3, 2023, the transaction closed in accordance with the terms of the agreement .\n Bunge entered into an agreement to sell substantially all of its wheat milling business in Mexico in exchange for cash proceeds approximately equal to the book value of property, plant and equipment, net, plus an additional sum in consideration for the value of net working capital to be transferred upon closing . Liabilities included in the disposal group comprised $6.6 million and $13.13 million, reported under the Agribusiness segment and Refined and Specialty Oils segment .\n The Company engages in various trade structured finance activities to leverage the value of its global trade flows . Bunge generally obtains U.S. dollar and foreign currency denominated letters of credit (\"LCs\") from financial institutions, each based on an underlying commodity trade flow, and time deposits denominated in dollars and foreign currencies, as well as foreign exchange forward contracts .\n All cash flows related to the programs are included in operating activities in the consolidated statements of cash flows . Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current liabilities, including any unrealized gain or loss on changes in changes in SOFR is not significant as of December 31, 2024, 2023 .\n The trade receivables securitization program (the \"Program\") with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers (collectively, the \"Purchasers\") Koninklijke Bunge B.V., a wholly owned subsidiary of Bunge, acts as master servicer, responsible for servicing and collecting the accounts receivable for the Program .\n Bunge Securitization B.V. transfers certain trade receivables to the Purchasers in exchange for a cash payment up to the aggregate size of the Program . The Program’s current pledge structure results from a November 16, 2022 amendment which replaced the existing deferred purchase price (\"DPP\") structure .\n The risk of loss following the sale of trade receivables is limited to the assets of BSBV . Bunge reports collections on newly originated, unsold receivable held by BSBv as operating cash flows in the consolidated statements of cash flows . The Company recognized the collection of the DPP in net cash provided by investing activities .\n The Company engages in trading and distribution, or merchandising activities . Included in the Company's RMI is $3,612 million and $4,242 million attributable to merchandizing activities at December 31, 2024 and 2023 . The balance includes certain advance payments on contracts with various unconsolidated investees see  Note 19- Related Party Transactions .\n The balance includes certain advance payments on contracts with various unconsolidated investees see  Note 19- Related Party Transactions . Bunge does not bear any of the costs or operational risks associated with growing the related crops . The ability of Bunge's counterparties to repay these amounts is affected by agricultural economic conditions in the relevant geography .\n The following is a summary of amounts recorded in the consolidated balance sheets as marketable securities and other short-term investments . Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities . As of December 31, 2024 and 2023, $386.386. million and $.67 million, respectively, of marketable investments are recorded at fair value .\n On October 1, 2024, Bunge completed the sale of our  50% ownership share in BP Bunge Bioenergia to BP . In connection with the sale, a disposition receivable of $100 million was recorded at December 31, 2024 and collected in early 2025 . The Company recognized an insurance recovery related to the Ukraine-Russia war of $298 million .\n If events or indicators of impairment occur between annual impairment analyses, the Company performs an impairment analysis at that date . These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or the sale or disposition of a significant asset . The Company recognizes an impairment charge for such amount, not to exceed the total amount of goodwill allocated to that reporting unit .\n The ying value of goodwill by reportable segment for the years ended December 31, 2024 and 2023 are as follows:. ying . The company's net assets, net are all finite-lived and consist of the following:. The net is the following . The net carrying value of the company's goodwill by the year of the year is as follows .\n The Company discontinued its use of several trademarks, primarily consisting of trademarks acquired in Bunge's 2018 acquisition of Loders Croklaan . The discontinuation triggered a reassessment of the trademarks' estimated useful lives resulting in accelerated amortization through December 31, 2023 . Amortization expense was $37.5 million, $39 million, and $41 million for the years of 2024 and 2022 .\n For the year ended December 31, 2023, Bunge recorded a pre-tax fixed asset impairment charge of $37.37.million in Cost of goods sold associated with a North America facility . The impairment charge was recorded to the Agribusiness segment . Bunge also recorded two (Loss) charges related to the full impairment of a long-term investment held in Other non-current assets .\n Bunge participates in various unconsolidated joint ventures and other investments accounted for using the equity method . The Company records its interest in the net earnings of its equity method investees, along with the amortization of basis differences, within (Loss) income from affiliates, in the consolidated statements of income . Basis differences represent differences between the cost of the investment and the underlying equity in net assets .\n Bunge has a 22-22% ownership interest in a company that has developed a novel low carbon-intensity winter oilseed crop called CoverCress™ . G3 Global Holding GP Inc. Inc. is a joint venture with Saudi Agricultural and Livestock Investment Company (\"SALIC\") that operates grain facilities in Canada . The Tapajos complex is mainly dedicated to exporting soybeans and grains from Brazil .\n Bunge has a joint venture, Terminal 6 S.A., in Argentina with AGD for the operation of a port facility located in the Santa Fe province of Argentina . Bunge is also a party to a second joint venture . The company has a 50% ownership interest in BP Bunge Bioenergia . On October 1, 2024, we completed the sale of our  purposefully50%-owned interest in BP  to BP . The acquisition price for Bunge's 25% interest in T-39 is Brazilian reais (\"R)\n T-39 operations primarily consist of a port facility located in the Port of Santos, Brazil . The transaction is expected to close in early 2025, subject to customary closing conditions . There is no carrying value associated with the equity method investments in Merit and APP at December 31, 2024, as a result of the impairments .\n On September 19, 2023, Bunge entered into a fixed-priced call option agreement to acquire the shares of Terminal de Granéis de Santa Catarina . The agreement required Bunge to make future installment payments for the Option which were utilized, in part, to fund terminal construction . Bunge expects to close on the acquisition in early 2025, subject to customary closing conditions .\n The following table presents the values of the assets and liabilities associated with the above listed VIEs in which Bunge is considered the primary beneficiary to the extent included in Bunge’s consolidated balance sheet as of December 31, 2024 and 2023 . All amounts exclude intercompany balances, which have been eliminated upon consolidation .\n Certain of these investments are variable interest entities for which Bunge has determined it is not the primary beneficiary . These investments are not consolidated by Bunge . Bunge's exposure to loss related to these unconsolidated investments is $740.740. and $589.589.million, respectively, as of December 31, 2024 and 2023 .\n A significant portion of these non-current assets arise primarily from Bunge's Brazilian operations and their realization could take several years . See  Note 20- Commitments and Contingencies- (Punge Global SA) and Subsidiaries' (F-33) summary of the company's financial statements .\n Long-term investments primarily comprise Bunge's noncontrolling equity investments in growth stage agribusiness and food companies held by Bunge Ventures . The average recorded investment in long-term receivables from farmers in Brazil for the years ended December 31, 2024 and 2023 was $67.67 per cent .\n The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil . New advances expected to be realized through farmer commitments to deliver agricultural commodities in crop periods greater than twelve months from the balance sheet date . Such advances are reclassified from Other non-current assets to Other current assets depending on the expected date of their realization .\n The Company records advances on sales when cash payments are received in advance of the Company's performance and recognizes revenue once the related performance obligation is completed . Bunge operates globally and is subject to the tax laws and regulations of numerous tax jurisdictions and authorities as well as tax agreements and treaties among these jurisdictions . The components of Income before income tax are as follows:\n The primary components of the deferred tax assets and liabilities and the related valuation allowances are as follows . Bunge recorded a net benefit for the amount that Bunge believes is more likely than not to be realized prior to expiration . During 2023, Bunge was granted tax credits in Switzerland that expire through 2032 .\n As of December 31, 2024, Bunge has determined it has unremitted earnings that are considered to be indefinitely reinvested of approximately $2.2 billion . Bunge would be subject to income taxes in the form of withholding taxes to the recipient for an amount of about $705 million . At December 31, 2023, pre-tax loss carryforwards totaled $.3.3 billion, of which $.1.1 billion have no expiration, including $1.7 billion in Brazil .\n At December 31, 2023, Bunge's tax credit carryforwards totaled $386454. rds . At Decem, $386.4 million of deferred tax credits are expiring within a ten year period and a portion that has no expiration . At Dec. 31, 2024 and 2023 Bunge has recorded valuation allowances of $595.595. million and $590.590 million, respectively .\n Bunge files income tax returns in the United States (federal and various states) and non-United States regions . As of December 31, 2024, Bunge's Brazilian subsidiaries have received income tax and penalty assesses . Bunge believes it is reasonably possible that approximately $20 million of its unrecognized tax benefits may be recognized by the end of 2025 as a result of a lapse of the statute of limitations .\n Management believes it is more likely than not that Bunge will prevail on the proposed assessments (with the exception of unrecognized tax benefits discussed above) in Brazil . The impact of the global minimum tax rules in 2024 was immaterial and is expected to be immaterial in 2025 as well . Bunge made cash income tax payments, net of refunds received, of $.520-million, $.655-million .\n The following table sets forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis . Bunge uses short- and long-term debt to fund operating requirements . The company's financial instruments also include derivative instruments and marketable securities . The fair value levels are based on the nature of business, Basis of Presentation and Significant Accounting Policies .\n These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business . Unrealized gains on derivative contracts are generally included in Other current assets . Cash equivalents primarily includes money market funds and commercial paper investments .\n RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where the Company's inventories are located . Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value .\n OTC derivative contracts include swaps, options, and structured transactions that are generally fair valued using quantitative models . Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities . The Company estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets .\n The following relates to assets and liabilities measured at fair value on a recurring basis using Level 3 measurements . An instrument may transfer into or out of Level 3 due to inputs becoming either observable or unobservable . Bunge's policy regarding the timing of transfers between levels is to record the transfers at the end of the reporting period .\n The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2024 and 2023 . These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant . Such inputs represent a significant component of the fair value of the securities held by the Company .\n The Company changed its reporting of purchases and sales activity within the readily marketable inventories Level 3 reconciliation to align with the Company's value chain trade flows and intended use . Prior period activity has been reclassified to conform to the current presentation . The Company's net losses are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at December 31, 2024 .\n The Company uses derivative instruments to manage several market risks, such as interest rate, foreign currency rate, and commodity risk . Some of the hedges the Company enters into qualify for hedge accounting (\"Hedge Accounting Derivatives\") and some, while intended as economic hedges, do not qualify or are not designated as hedge accounting . As these derivatives impact the financial statements, they are discussed separately below .\n The Company manages currency risk on certain forecasted purchases, sales, and selling, general and administrative expenses with currency forwards . The Company monitors these relationships on a quarterly basis and performs a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative .\n The Company hedges the currency risk of certain of its foreign subsidiaries with currency forwards . Currency forwards are classified in Accumulated other comprehensive loss until the transaction affects earnings by way of either sale or substantial liquidation of the foreign subsidiary . The notional amount of derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap)\n The Company enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations . Interest rate derivatives are used to hedge exposures to the Company's financial instrument portfolios and debt issuances . Currency and agricultural commodities are used primarily to manage exposures . The impact of changes in fair value of these instruments is presented in Cost of goods sold .\n The Company uses energy derivative instruments to manage its exposure to volatility in energy costs . Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel . The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives . The impact of changes in fair value of these instruments is presented in Cost of goods sold .\n The tables below summarize the net effect of derivative instruments and hedge accounting on the consolidated statements of income for the years ended December 31, 2024, 2023, and 2022 . Table of Contents includes the tables below . Table includes the table of financial statements to the consolidated statements to the consolidated financial statement of the companies . Table includes the net effect of derivative investments and hedge accounts and the net effect of derivative insights and hedges .\n The following table summarizes Bunge's short and long-term debt: Short-term debt and Current portion of long-term . Debt: $1.5 billion -  - $1.4 billion . Bunge has a long-standing debt of $2.1 billion .\n The fair value of Bunge's long-term debt is calculated based on interest rates . Bunge increased the aggregate size of its existing commercial paper program by $1.1 billion to an aggregate of $2 billion in 2024 . On September 30, 2024, Bunge prepaid and terminated its  3-year term loan agreement due in 2025 .\n Bunge rminated the Bunge Master Trust in accordance with a termination and lien release agreement in order to simplify the legal framework around its capital structure . Bunge continues to conduct most of its third-party financing activities centrally through 100% owned finance subsidiaries which carry full, unconditional guarantees of the parent company . The weighted-average interest rate on short-term borrowings at December 31, 2024 and 2023 was  6.22% and  8.36% .\n Borrowings bear interest at SOFR plus a SOFR adjustment and applicable margin . Bunge had no borrowings outstanding at December 31, 2024, and 2023, under the $-3.2.2 billion Revolving Credit Agreement and the predecessor agreement, respectively . The $3.5 billion revolving credit agreement matures on October 6, 2026 . The funding cost is also subject to certain premiums or discounts tied to sustainability criteria .\n Bunge had no borrowings outstanding at December 31, 2024, and 2023, under the $3.5.5 billion Revolving Facility Agreement and the predecessor agreement, respectively . Bunge amended and restated its existing $1.1 billion  revolving credit agreement with a group of lenders, to extend the maturity date from June 19, 2024 to April 11, 2025 . Borrowings will bear interest at SOFR plus a credit spread adjustment and applicable margin, as defined in the $865 million Revolving Credit Facility .\n Bunge increased the aggregate size of its existing commercial paper program by $1.1 billion to an aggregate of $2.2 billion . Borrowings under the $2 billion Commercial Paper Program typically have an original maturity of three months or less, resulting in net presentation of proceeds and repayments of short-term debt in the consolidated statements of cash flows .\n Bunge secured a total of $8.0-billion in Acquisition Financing in the form of a $7.7-billion financing commitment from a consortium of lenders, arranged by Sumitomo Mitsui Banking Corporation . Bunge completed the sale and issuance of (i) $395.4.100% senior notes due 2028, (ii) $400.400-million aggregate principal amount of  grotesquely-preferred notes due 2029, and (iii) $798.800-per-year Senior Notes due 2034 . The Senior Notes are fully and unconditionally guaranteed by Bunge .\n The net proceeds from the offering are expected to be used to fund a portion of the cash consideration for Bunge's Acquisition of Viterra . The Senior Notes are subject to a special mandatory redemption at a price equal to  around 101% of the aggregate principal amount, plus accrued and unpaid interest, under certain circumstances .\n The US Exchange Offers and European Consent Solicitation are conditioned, among other things, upon the consummation of the Acquisition . The Existing USD Viterra Notes are not recognized on Bunge's condensed consolidated balance sheet, until the acquisition . The resolutions to effect such amendments have been passed by the requisite number of noteholders .\n During the years ended December 31, 2024, 2023, and 2022, Bunge paid interest, net of interest capitalized, of $434.2 million . The funding policies for Bunge's defined benefit pension plans are determined in accordance with statutory funding requirements . The most significant defined benefit plan is in the United States .\n The insurance buy-in contract is a group annuity contract that is expected to provide an income stream to cover a significant majority of the cash flows arising for the plan population . However, the benefit obligation remains with the plan and the Company . Bunge does not expect the transaction to result in material cash inflows or outflows .\n On February 28, 2022, Bunge agreed to the transition of one of the Company’s international defined-benefit pension plans to a multi-employer pension plan . The payments, which were paid from plan assets as settlement of respective benefit obligations, resulted in a $22.2billion decrease in benefit obligations and the reclassification of an unamortized gain of less than $2billion from Accumulated other comprehensive loss .\n Amortization of net loss represents recognition in net periodic cost over several periods of amounts previously recognized in Other comprehensive (loss) income . Service cost is included in the same income statement line item as other compensation costs arising from services rendered during the period . The expected return on plan assets is determined based on the expected long-term rate of return on the plan assets and the market-related value of plan assets .\n The weighted-average actuarial assumptions used in determining the benefit obligation under the defined benefit pension and postretirement benefit plans are as follows . The sponsoring subsidiaries select the expected long-term rate of return on assets in consultation with their investment advisors and actuaries . Cash flows and expenses are taken into consideration to the extent that it would affect the expected returns . The plans are assumed to continue in effect as long as assets are expected to be invested .\n The following table sets forth in aggregate the changes in the defined benefit pension and postretirement benefit plans' benefit obligations, assets and funded status at December 31, 2024 and 2023 . For certain of Bunge’s plans, the discount rate is based on the rate at which the liabilities will be effectively settled during 2025 . For the U.S. Pension Plan, the anticipated long-term rate of return is equal to the discount .\n Unfunded status and net amounts recognized . Net amounts recognized: Net liability recognized in the balance sheet . Accumulated other comprehensive loss are the following amounts, net of tax and excluding noncontrolling interest, which have not been recognized in net periodic benefit costs:  Net actuarial (loss) gain .\n The following table summarizes information related to aggregated defined benefit pension plans with an accumulated benefit obligation in excess of plan assets . The objective of the plans' trust funds is to sufficiently diversify plan assets to maintain a reasonable level of risk without imprudently sacrificing returns . For pension plans in the United States, Bunge has an outside investment advisory firm to implement a liability-driven investment strategy .\n The Company's policy is not to invest plan assets in Bunge Global SA shares . Plan investments are stated at fair value or net asset value (\"NAV\") Bunge implements its investment strategy through a combination of passive and actively managed strategies . The fair values of Bunge's defined benefit pension plans' assets at the measurement date, by category, are as follows .\n Investments measured at NAV as a practical expedient are not categorized within the fair value hierarchy, but are included in the table above so that they can be reconciled to the line items presented in the consolidate table above . The U.S. Pension Plan buy-in contract related to the pension plan was valued on an insurer pricing basis, which reflects the purchase price .\n The following benefit payments, which reflect future service as appropriate, are expected to be paid in relation to defined benefit pension and postretirement benefit plans . Bunge also makes contributions to qualified defined contribution plans for eligible employees . The expected benefit payments in 2025 include $395 million related to the anticipated settlement of the U.S. Pension Plan as discussed above .\n The Company provides certain advance payments for future delivery of specified quantities of agricultural commodities and advances to its unconsolidated invectors . During the years ended December 31, 2024, 2023, and 2022, such services wwere not material to trulyhe Company's consolidated results . The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties .\n Brazilian authorities have concluded examinations of ICMS and PIS/COFINS tax returns and have issued outstanding claims . The Company continues to evaluate the merits of each of these claims and will recognize them if and when loss is considered probable . There exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period the uncertainties are resolved should the liability substantially exceed the  F-56F-56 valuation .\n Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates . Terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2034 . There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees .\n At December 31, 2024, Bunge recorded a $395.9 million obligation related to existing indemnity claims within Other non-current liabilities . Bunge has issued or was a party to the following indemnities at December 31, 2024 . Indemnities for new claims generally expire between  six-six-years from the transaction closing date and no expiration period for existing claims .\n At December 31, 2024, Bunge recorded a $395.5 million obligation related to certain indemnifications associated with the sale of it 50% ownership interest in BP Bunge Bioenergia . Bunge has entered into standby letters of credit and surety bonds with financial institutions primarily relating to the guarantee of our future performance on certain contracts . Other non-current liabilities consist of the following: Labor, legal and other provisions .\n One registered share, par value $0.01 per share, of Bunge Global SA was exchanged for,  each issued and outstanding Bunge Limited common share . Bunge acquired  receive 16,141,494 shares on November 1, 2023 . In connection with the Redomestication, 8,102,179Shares held in treasury were cancelled in a non-cash transaction to comply with the Swiss Code limitation on issuer’s holding of registered share capital .\n All of Bunge Global SA's issued and outstanding convertible preference shares were automatically converted into common shares of the Company, par value $0.01 per share . There were  6,898,268,268 convertible preference shareholders' rights terminated, as of March 23, 2022, and all rights of the former holders of the convertible preferred shares terminated . The convertible preference share dividends ceased to accrue on the conversion date .\n Upon approval of a dividend, the obligation is reflected in Other current liabilities . At December 31, 2024, and 2023, the unpaid portion of the dividends accrued in Other Current liabilities on the consolidated balance sheets totaled $.91.00 million and $.96 million, respectively, see  Note 13- Other Current Liabilities .\n Bunge has significant operating subsidiaries in Brazil, Argentina, North America, Europe, and Asia-Pacific . The functional currency of Bunge's subsidiaries is generally the local currency . The assets and liabilities of these subsidiaries are translated into U.S. dollars from local currency at month-end exchange rates . The resulting foreign currency translation gains (losses) are recorded in the consolidated balance sheets as a component of Accumulated other comprehensive loss .\n The following table sets forth the computation of basic and diluted earnings per share . Earnings per share have been calculated based on Bunge’s common shares prior to the Redomestication . The following information includes references to Net income attributable to Bunge shareholders, Weighted-average number of shares outstanding, and Earnings Per Share information .\n In connection with the Redomestication effective as of November 1, 2023, Bunge amended the Bunge Equity Incentive Plan (the 2016 EIP) and the 2017 Non-Employee Directors equity Incenture Plan . The weighted-average shares outstanding-diluted exclude less than  preferred preference shares, which were not dilutive and not included in the computation of earnings per share .\n For the years ended December 31, 2024, 2023, and 2022, Bunge recognized approximately $65.9 million, $.69 million, and $.65 million, respectively, of total compensation expense related to its stock option and restricted stock unit equity awards . Under the 2024 LTIP and the 2016 EIP, the Compensation Committee of Bunge's Board of Directors may grant equity-based awards to officers, employees, consultants, and independent contractors in the form of stock options, restricted stock units .\n Bunge elected to cease awarding stock options to its employees beginning January 1, 2021 . All awards previously granted have vested and have varying expiration dates through 2030 . Restrictions on TBRSUs are based on continued service by the recipient through the designated term, with PBRSUs based on the achievement of certain performance targets . RSUs are generally settled in Bunge registered shares upon satisfaction of the applicable vesting terms .\n The fair value of each stock option granted under any of the Plans is estimated on the grant date using the Black-Scholes-Merton option pricing model . At the time of settlement, a participant holding a vested restricted stock unit is also entitled to receive corresponding accrued dividend equivalent share payments . The total intrinsic value of options exercised during the years ended December 31, 2024, 2023, and 2022 was approximately $5.5 million .\n Bunge issued a total of  638,386 registered shares, net of shares withheld to cover taxes, including related shares representing accrued dividends, with a weighted-average fair value of $85.90 per share upon vesting of TBRSUs and PBRSUs . The 2024 LTIP and 2017 NED Plan provide that  5,000,000 and  320,000 registered shares are to be reserved for grants of stock options, restricted stock units a share .\n The accounting for some of the Company's leases may require significant judgment when determining whether a contract is or contains a lease . Leases with an initial term of more than 12 months are recognized on the balance sheet as right-of-use assets (Operating lease assets) and lease liabilities for the obligation to make payments under such leases .\n Short-term leases are not recorded on the consolidated balance sheets and the related lease expense is recognized on a straight-line basis over the lease term . Renewal options are generally exercisable solely at the Company’s discretion . As of December 31, 2024, such weighted average discount rate on operating leases was  4.7%%.\n Certain of the Company’s lease agreements related to railcars and barges contain residual value guarantees (see  Note 20- Commitments and Contingencies) The components of lease expense were as follows: Operating lease cost $. in the period in which the adjustment to the variable payment obligation is incurred .\n Sublease income, generally recorded within Net sales, was $229 million and $176 million for the years ended December 31, 2024 and 2023, respectively . Subleases primarily relate to agreements with third parties for the use of portions of certain facilities with remaining sublease terms of up to five years . The Company's remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other .\n The Refined and Specialty Oils segment involves the processing, production, and marketing of products derived from vegetable oils . The Sugar & Bioenergy segment comprises the net earnings from the Company’s 50% interest in BP Bunge Bioenergia, a joint venture with BP . Corporate and Other includes salaries and overhead for corporate functions that are not allocated to the Company's individual reporting segments .\n Reportable Segments: BUNGE GLOBAL SA AND SUBSIDIARIES. (Continued)  Bunge Consolidated. ions. ions                                 -  - BUNge consolidated financial statements were completed in December 31, 2023(US$ in millions) in millions)\n As of the year ended December 31, 2022, the company reported net sales to external customers were $2,786 . The company reported total sales to $10,200,000, Net sales to excessions to external customers revenue to external customers were $1,700,000 . The Company reported total revenues to $8,360,000 in the year ended December 31, 2022 . The net sales were $1,800,000 to $1.8,000 per annuity sales . Net foreign exchange gains were $9,000 less than the $2.2,000 a year ago .\n The Bunge Global SA and SUBSIDIARIES (Continued) report has been published by Bunge Group . The report was published by BUNGE Global SA SA and Subsidiaries (Bunge Global SSA) Report: The company announced a joint venture with Viterra, Bunge's share in BP Bunge Bioenergia, and other noncontrolling interests, respectively .\n EBIT includes a mark-to-market gain of $29.2 million, recorded in Cost of goods sold, related to inventory recovered from Bunge's Mykolaiv and other facilities in Ukraine . $37.3 million of fixed asset impairment charges in North America,   related to the announced Business Combination Agreement with Viterra . $20 million impairment charge related to a minority investment in Australian Plant Proteins .\n Total reportable segment earnings before interest and taxes (\"EBIT\") is the key operating performance measure utilized by the CODM . EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industries . The measure allows for an evaluation of the performance of its reportable segments without regard to its financing methods or capital structure .\n Geographic area information for Net sales to external customers, determined based on the location of the subsidiary making the sale, and long-lived assets follows . The Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging  Derivatives and Hedging (ASC 815) and sales of other products and services that are accounted for under ASC 606 .\n The company's net sales from contracts with customers (ASC 606) and net net sales to external customers (AS 606), receiving financial statements from contracts with customers, and Net sales to external customers were prepared to receive net sales . The Company's net income attributable to Bunge shareholders was preferred by Bunge shareholders per share in the further period of 2023 .\n The sum of the quarterly earnings per share for the years ended December 31, 2024 and 2023 may not equal the total computed for the year . The Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized . See  Note 23- Earnings per Share for further details .\n Executive Vice President and Chief Financial Officer J. Matt Simmons, Jr., J. Matt Simmons, J. J. N. Neppl. Heelie Aleixo Lustosa de Andrade. The Board of Directors will hold office on February 20, 2025 . The Board will meet at the end of the year on March 21, 2018 ."
}